Mechanism of pyruvate dehydrogenase activation by increased cardiac work - PubMed (original) (raw)
Mechanism of pyruvate dehydrogenase activation by increased cardiac work
K Kobayashi et al. J Mol Cell Cardiol. 1983 Jun.
Abstract
The effects of increased cardiac work, pyruvate and insulin on the state of pyruvate dehydrogenase (PDH) activation and rate of pyruvate decarboxylation was studied in the isolated perfused rat heart. At low levels of cardiac work, 61% of PDH was present in the active form when glucose was the only substrate provided. The actual rate of pyruvate decarboxylation was only 5% of the available capacity calculated from the percent of active PDH. Under this condition, the rate of pyruvate decarboxylation was restricted by the slow rate of pyruvate production from glycolysis. Increasing cardiac work accelerated glycolysis, but production of pyruvate remained rate limiting for pyruvate oxidation and only 40% of the maximal active PDH capacity was used. Addition of insulin along with glucose reduced the percent of active PDH to 16% of the total at low cardiac work. This effect of insulin was associated with increased mitochondria NADH/NAD and acetyl CoA/CoA ratios. With both glucose and insulin the calculated maximum capacity of active PDH was about the same as measured rates of pyruvate oxidation indicating that pyruvate oxidation was limited by the activation state of PDH. In this case, raising the level of cardiac work increased the active PDH to 85% and although pyruvate oxidation was accelerated, measured flux through PDH was only 73% of the maximal activity of active PDH. With pyruvate as added exogenous substrate, PDH was 82% of active at low cardiac work probably due to pyruvate inhibition of PDH kinase. In this case, the measured rate of pyruvate oxidation was 64% of the capacity of active PDH. However, increased cardiac work still caused further activation of PDH to 96% active. Thus, actual rates of pyruvate oxidation in the intact tissue were determined by (1) the supply of pyruvate in hearts receiving glucose alone, (2) by the percent of active PDH in hearts receiving both glucose and insulin at low work and (3) by end-product inhibition in hearts receiving glucose and insulin at high work or at all levels of work with pyruvate as substrate. The increase in active PDH with higher levels of cardia work was associated most closely with reduced mitochondrial NADH/NAD ratios and with decreased acetyl CoA/CoA ratios when insulin or pyruvate were present.
Similar articles
- Effects of increased cardiac work on pyruvate dehydrogenase activity in hearts from diabetic animals.
Kobayashi K, Neely JR. Kobayashi K, et al. J Mol Cell Cardiol. 1983 Jun;15(6):347-57. doi: 10.1016/0022-2828(83)90319-x. J Mol Cell Cardiol. 1983. PMID: 6876184 - Pyruvate dehydrogenase influences postischemic heart function.
Lewandowski ED, White LT. Lewandowski ED, et al. Circulation. 1995 Apr 1;91(7):2071-9. doi: 10.1161/01.cir.91.7.2071. Circulation. 1995. PMID: 7895366 - Energy-linked regulation of glucose and pyruvate oxidation in isolated perfused rat heart. Role of pyruvate dehydrogenase.
Hiltunen JK, Hassinen IE. Hiltunen JK, et al. Biochim Biophys Acta. 1976 Aug 13;440(2):377-90. doi: 10.1016/0005-2728(76)90072-4. Biochim Biophys Acta. 1976. PMID: 182244 - Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.
Calvani M, Reda E, Arrigoni-Martelli E. Calvani M, et al. Basic Res Cardiol. 2000 Apr;95(2):75-83. doi: 10.1007/s003950050167. Basic Res Cardiol. 2000. PMID: 10826498 Review. - Glucose fatty acid interactions and the regulation of glucose disposal.
Randle PJ, Priestman DA, Mistry SC, Halsall A. Randle PJ, et al. J Cell Biochem. 1994;55 Suppl:1-11. doi: 10.1002/jcb.240550002. J Cell Biochem. 1994. PMID: 7929613 Review.
Cited by
- Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy.
Elnwasany A, Ewida HA, Szweda PA, Szweda LI. Elnwasany A, et al. Antioxidants (Basel). 2023 Mar 20;12(3):756. doi: 10.3390/antiox12030756. Antioxidants (Basel). 2023. PMID: 36979003 Free PMC article. Review. - CARDIOKIN1: Computational Assessment of Myocardial Metabolic Capability in Healthy Controls and Patients With Valve Diseases.
Berndt N, Eckstein J, Wallach I, Nordmeyer S, Kelm M, Kirchner M, Goubergrits L, Schafstedde M, Hennemuth A, Kraus M, Grune T, Mertins P, Kuehne T, Holzhütter HG. Berndt N, et al. Circulation. 2021 Dec 14;144(24):1926-1939. doi: 10.1161/CIRCULATIONAHA.121.055646. Epub 2021 Nov 11. Circulation. 2021. PMID: 34762513 Free PMC article. Clinical Trial. - The Ryanodine Receptor as a Sensor for Intracellular Environments in Muscles.
Kobayashi T, Kurebayashi N, Murayama T. Kobayashi T, et al. Int J Mol Sci. 2021 Oct 6;22(19):10795. doi: 10.3390/ijms221910795. Int J Mol Sci. 2021. PMID: 34639137 Free PMC article. Review. - Open-Loop Control of Oxidative Phosphorylation in Skeletal and Cardiac Muscle Mitochondria by Ca(2.).
Vinnakota KC, Singhal A, Van den Bergh F, Bagher-Oskouei M, Wiseman RW, Beard DA. Vinnakota KC, et al. Biophys J. 2016 Feb 23;110(4):954-61. doi: 10.1016/j.bpj.2015.12.018. Biophys J. 2016. PMID: 26910432 Free PMC article. - Regulation of cardiac cellular bioenergetics: mechanisms and consequences.
Tran K, Loiselle DS, Crampin EJ. Tran K, et al. Physiol Rep. 2015 Jul;3(7):e12464. doi: 10.14814/phy2.12464. Physiol Rep. 2015. PMID: 26229005 Free PMC article.